OTC Markets OTCQB - Delayed Quote USD

Hestia Insight Inc. (HSTA)

Compare
0.1500
0.0000
(0.00%)
At close: April 2 at 4:00:00 PM EDT
Loading Chart for HSTA
  • Previous Close 0.1500
  • Open 0.1500
  • Bid 0.0611 x --
  • Ask 0.2500 x --
  • Day's Range 0.1500 - 0.1500
  • 52 Week Range 0.0560 - 0.2877
  • Volume 16
  • Avg. Volume 98
  • Market Cap (intraday) 4.191M
  • Beta (5Y Monthly) -0.06
  • PE Ratio (TTM) 7.50
  • EPS (TTM) 0.0200
  • Earnings Date Apr 21, 2025 - Apr 25, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Hestia Insight Inc. provides corporate advisory services to private and public companies with focus on the biotech and healthcare sectors. Th company assists private and public companies and entrepreneurs on a range of U.S. capital markets transactions and investment opportunities across an array of industries and sectors. It services include strategic planning, M&A, capital market advisory, IPO consulting, technology transfer, etc. The company was formerly known as Luxshmi Investments, Inc. and changed its name to Hestia Insight Inc. in May 2019. Hestia Insight Inc. was incorporated in 2003 and is based in Las Vegas, Nevada.

www.hestiainsight.com

3

Full Time Employees

November 30

Fiscal Year Ends

Recent News: HSTA

View More

Performance Overview: HSTA

Trailing total returns as of 4/3/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

HSTA
25.00%
S&P 500 (^GSPC)
8.25%

1-Year Return

HSTA
4.46%
S&P 500 (^GSPC)
3.55%

3-Year Return

HSTA
95.00%
S&P 500 (^GSPC)
18.71%

5-Year Return

HSTA
98.64%
S&P 500 (^GSPC)
116.85%

Compare To: HSTA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: HSTA

View More

Valuation Measures

Annual
As of 4/2/2025
  • Market Cap

    4.19M

  • Enterprise Value

    3.16M

  • Trailing P/E

    7.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.35

  • Price/Book (mrq)

    4.46

  • Enterprise Value/Revenue

    2.53

  • Enterprise Value/EBITDA

    4.26

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    51.38%

  • Return on Assets (ttm)

    79.38%

  • Return on Equity (ttm)

    114.84%

  • Revenue (ttm)

    1.25M

  • Net Income Avi to Common (ttm)

    642.21k

  • Diluted EPS (ttm)

    0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.11M

  • Total Debt/Equity (mrq)

    8.39%

  • Levered Free Cash Flow (ttm)

    751.66k

Research Analysis: HSTA

View More

Company Insights: HSTA

Research Reports: HSTA

View More

People Also Watch